Skip to main content
. 2020 Apr 28;9(5):445–456. doi: 10.1530/EC-20-0129

Table 3.

Reported presenting features and severity of adrenal insufficiency patients under the care of the responding physicians.

Patients’ characteristics SSAa (n = 2885) MENAa (n = 2902) P-valueb Total (%, 95% CI) P-valuec
Presenting featuresd
 Gastrointestinal symptoms 227 (82.2) 52 (92.9) 0.047 279 (84.0, 79.6–87.8)
 Nausea 188 (79.7) 46 (86.8) 0.232 234 (81.0, 76.0–85.3) Reference
 Vomiting 174 (73.7) 43 (82.7) 0.175 217 (75.3, 69.9–80.2) 0.076
 Diarrhoea 153 (66.2) 43 (86.0) 0.006 196 (69.7, 64.0–75.1) <0.001
 Abdominal pain 168 (71.2) 47 (90.4) 0.004 215 (74.6, 69.2–79.6) 0.047
 Anorexia 164 (71.0) 42 (80.8) 0.152 206 (72.8, 67.2–77.9) 0.012
Non-specific features
 Dizziness 188 (79.7) 49 (92.4) 0.029 237 (82.0, 77.1–86.3) Reference
 Weight loss 187 (77.3) 47 (88.7) 0.063 234 (79.3, 74.2–83.8) 0.378
 Salt craving 116 (50.7) 30 (62.5) 0.135 146 (52.7, 46.6–58.7) <0.001
 Skin pigment 154 (65.8) 40 (75.5) 0.175 194 (67.6, 61.8–73.0) <0.001
 Backache 115 (50.0) 29 (56.9) 0.375 144 (51.3, 45.2–57.2) <0.001
Adrenal crisis 242 (16.4) 134 (16.2) 0.884 376 (16.3, 14.8–17.9)
Features suggestive of adrenal crisis
 Hypoglycaemia 162 (67.8) 40 (76.9) 0.195 202 (69.4, 63.8–74.6) Reference
 Loss of consciousness 97 (42.5) 21 (42.9) 0.968 118 (42.6, 36.7–48.6) <0.001
 Shock 127 (54.3) 29 (55.8) 0.845 156 (54.6, 48.6–60.4) <0.001

aResults are expressed as number (percentage); bP-value: comparison of clinical characteristics of patients between SSA and MENA; cP-value: comparison of all the patients in the entire cohort; dPercentages of common presenting features according to respondent doctors (n = 276 for SSA and 56 for MENA).